SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-005344
Filing Date
2024-01-22
Accepted
2024-01-22 06:04:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2334010-2_424b5.htm 424B5 655331
2 GRAPHIC lg_esperion-4c.jpg GRAPHIC 22945
3 GRAPHIC tb_inhibitor-4lr.jpg GRAPHIC 48996
  Complete submission text file 0001104659-24-005344.txt   754437
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264303 | Film No.: 24546998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)